Optimizing the synthesis of clinical trial data using sequential trees
暂无分享,去创建一个
[1] Simon Hediger,et al. On the use of random forest for two-sample testing , 2019, Comput. Stat. Data Anal..
[2] Bernhard Pfahringer,et al. Classifier Chains: A Review and Perspectives , 2019, J. Artif. Intell. Res..
[3] K. El Emam. Seven Ways to Evaluate the Utility of Synthetic Data , 2020, IEEE Security & Privacy.
[4] Linda Coyle,et al. Generation and evaluation of synthetic patient data , 2020, BMC Medical Research Methodology.
[5] Ziqi Zhang,et al. Generating Electronic Health Records with Multiple Data Types and Constraints , 2020, AMIA.
[6] Daniel S Quintana,et al. A synthetic dataset primer for the biobehavioural sciences to promote reproducibility and hypothesis generation , 2020, eLife.
[7] E. Akl,et al. Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide , 2019, BMC Medical Research Methodology.
[8] J. Prchal,et al. Aberrant expression of microRNA in polycythemia vera , 2008, Haematologica.
[9] Thomas Sutter,et al. Generation of Heterogeneous Synthetic Electronic Health Records using GANs , 2019, NeurIPS 2019.
[10] S. Nevitt,et al. European Medicines Agency Policy 0070: an exploratory review of data utility in clinical study reports for academic research , 2019, BMC Medical Research Methodology.
[11] Yi Feng,et al. The Promise and Limitations of Synthetic Data as a Strategy to Expand Access to State-Level Multi-Agency Longitudinal Data , 2019, Journal of Research on Educational Effectiveness.
[12] Allan Tucker,et al. Generating and Evaluating Synthetic UK Primary Care Data: Preserving Data Utility & Patient Privacy , 2019, 2019 IEEE 32nd International Symposium on Computer-Based Medical Systems (CBMS).
[13] Jingchen Hu,et al. Bayesian Estimation of Attribute and Identification Disclosure Risks in Synthetic Data , 2018, Trans. Data Priv..
[14] Latanya Sweeney,et al. Saying it’s Anonymous Doesn't Make It So: Re-identifications of “anonymized” law school data , 2018 .
[15] Latanya Sweeney,et al. Risks to Patient Privacy: A Re-identification of Patients in Maine and Vermont Statewide Hospital Data , 2018 .
[16] Josep Domingo-Ferrer,et al. On the Privacy Guarantees of Synthetic Data: A Reassessment from the Maximum-Knowledge Attacker Perspective , 2018, PSD.
[17] Maria Pampaka,et al. Differential Correct Attribution Probability for Synthetic Data: An Exploration , 2018, PSD.
[18] Ruben C. Arslan,et al. Using 26,000 diary entries to show ovulatory changes in sexual desire and behavior. , 2018, Journal of personality and social psychology.
[19] Sushil Jajodia,et al. Data Synthesis based on Generative Adversarial Networks , 2018, Proc. VLDB Endow..
[20] I. Salama,et al. Artificial Intelligence in Health Care , 2018 .
[21] David Moher,et al. Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine , 2018, British Medical Journal.
[22] Joshua R Polanin,et al. Efforts to retrieve individual participant data sets for use in a meta-analysis result in moderate data sharing but many data sets remain missing. , 2017, Journal of clinical epidemiology.
[23] Zhiwei Steven Wu,et al. Privacy-Preserving Generative Deep Neural Networks Support Clinical Data Sharing , 2017, bioRxiv.
[24] Laurie Harris,et al. Overcoming Small Data Limitations in Heart Disease Prediction by Using Surrogate Data , 2018 .
[25] G. Raab,et al. Guidelines for Producing Useful Synthetic Data , 2017, 1712.04078.
[26] Bill Howe,et al. Synthetic Data for Social Good , 2017, ArXiv.
[27] Gillian M. Raab,et al. Providing bespoke synthetic data for the UK Longitudinal Studies and other sensitive data with the synthpop package for R1 , 2017 .
[28] Zbigniew Michalewicz,et al. Particle Swarm Optimization for Single Objective Continuous Space Problems: A Review , 2017, Evolutionary Computation.
[29] Ji Su Yoo,et al. Re-identification Risks in HIPAA Safe Harbor Data: A study of data from one environmental health study. , 2017, Technology science.
[30] Gillian M. Raab,et al. Practical Data Synthesis for Large Samples , 2018, J. Priv. Confidentiality.
[31] Joshua Snoke,et al. General and specific utility measures for synthetic data , 2016, 1604.06651.
[32] H. Bauchner,et al. Sharing Clinical Trial Data: A Proposal from the International Committee of Medical Journal Editors , 2016, PLoS medicine.
[33] Michael J. Pencina,et al. Use of Open Access Platforms for Clinical Trial Data. , 2016, JAMA.
[34] H. Bauchner,et al. Sharing Clinical Trial Data: A Proposal from the International Committee of Medical Journal Editors , 2016, Ethiopian journal of health sciences.
[35] Jerome P. Reiter,et al. Releasing synthetic magnitude microdata constrained to fixed marginal totals , 2016 .
[36] P. Ravaud,et al. Feasibility of individual patient data meta-analyses in orthopaedic surgery , 2015, BMC Medicine.
[37] B. Lo. Sharing clinical trial data: maximizing benefits, minimizing risk. , 2015, JAMA.
[38] Y. de Montjoye,et al. Unique in the shopping mall: On the reidentifiability of credit card metadata , 2015, Science.
[39] B. Nowok. Utility of synthetic microdata generated using tree-based methods , 2015 .
[40] Yoshua Bengio,et al. Generative Adversarial Nets , 2014, NIPS.
[41] Malika Charrad,et al. NbClust: An R Package for Determining the Relevant Number of Clusters in a Data Set , 2014 .
[42] Jerome P. Reiter,et al. Disclosure Risk Evaluation for Fully Synthetic Categorical Data , 2014, Privacy in Statistical Databases.
[43] Kristian Thorlund,et al. Reanalyses of randomized clinical trial data. , 2014, JAMA.
[44] Peggy Eastman,et al. IOM Attempting to Set Principles for Responsible Clinical Trial Data Sharing , 2014 .
[45] Lane F Burgette,et al. A tutorial on propensity score estimation for multiple treatments using generalized boosted models , 2013, Statistics in medicine.
[46] S. Faivre,et al. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. , 2013, The Lancet. Oncology.
[47] Latanya Sweeney,et al. Matching Known Patients to Health Records in Washington State Data , 2013, ArXiv.
[48] César A. Hidalgo,et al. Unique in the Crowd: The privacy bounds of human mobility , 2013, Scientific Reports.
[49] Khaled El Emam,et al. A Review of Evidence on Consent Bias in Research , 2013, The American journal of bioethics : AJOB.
[50] Grigorios Tsoumakas,et al. Multi-target regression via input space expansion: treating targets as inputs , 2012, Machine Learning.
[51] Jörg Drechsler,et al. An empirical evaluation of easily implemented, nonparametric methods for generating synthetic datasets , 2011, Comput. Stat. Data Anal..
[52] Geoff Holmes,et al. Classifier chains for multi-label classification , 2009, Machine Learning.
[53] Wei-Yin Loh,et al. Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..
[54] Claudio Conversano,et al. Incremental Tree-Based Missing Data Imputation with Lexicographic Ordering , 2009, J. Classif..
[55] Jason Weston,et al. Curriculum learning , 2009, ICML '09.
[56] Anna Oganian,et al. Global Measures of Data Utility for Microdata Masked for Disclosure Limitation , 2009, J. Priv. Confidentiality.
[57] Daniel J. Freeman,et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] Riccardo Poli,et al. Analysis of the publications on the applications of particle swarm optimisation , 2008 .
[59] Peter Buhlmann,et al. BOOSTING ALGORITHMS: REGULARIZATION, PREDICTION AND MODEL FITTING , 2007, 0804.2752.
[60] Marc Peeters,et al. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[61] K. Hornik,et al. Unbiased Recursive Partitioning: A Conditional Inference Framework , 2006 .
[62] A. Karr,et al. Data swapping as a decision problem , 2005 .
[63] P. Qiu. The Statistical Evaluation of Medical Tests for Classification and Prediction , 2005 .
[64] Jerome P. Reiter,et al. Releasing multiply imputed, synthetic public use microdata: an illustration and empirical study , 2005 .
[65] Jerome P. Reiter,et al. Using CART to generate partially synthetic public use microdata , 2005 .
[66] Jerome P. Reiter,et al. New Approaches to Data Dissemination: A Glimpse into the Future (?) , 2004 .
[67] Lorenzo Rosasco,et al. Are Loss Functions All the Same? , 2004, Neural Computation.
[68] J. Friedman. On Multivariate Goodness-of-Fit and Two-Sample Testing , 2004 .
[69] T. N. Sriram. Asymptotics in Statistics–Some Basic Concepts , 2002 .
[70] A. Kovatich,et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[71] D. Wallace. The Yale School of Medicine , 1934, Science.